Literature DB >> 32519018

Birth prevalence of congenital heart disease in China, 1980-2019: a systematic review and meta-analysis of 617 studies.

Lijuan Zhao1, Lizhang Chen2,3, Tubao Yang1, Tingting Wang1, Senmao Zhang1, Letao Chen1, Ziwei Ye1, Liu Luo1, Jiabi Qin4,5,6.   

Abstract

To assess the birth prevalence and spatial distribution of congenital heart disease (CHD) in China by conducting a complete overview and using spatial epidemiological methods. Unrestricted searches were conducted on seven electronic databases, with an end-date parameter of May 2019. Data on the birth prevalence of CHD and its subtypes were collected and combined using either the random-effect model or fixed-effect model. Subgroup sensitivity analyses were performed to explore potential heterogeneity moderators. The three-dimensional trend analysis and a visualization of CHD birth prevalence among different provinces were performed to describe the spatial distribution characteristics. Total 617 studies involving 76,961,354 births and 201,934 CHD individuals were included. Overall, total CHD birth prevalence increased continuously over time, from 0.201‰ in 1980-1984 to 4.905‰ in 2015-2019. The study on the high-income provinces, population-based monitoring model, male births, and urban regions reported a significantly higher prevalence of total CHD compared with upper-middle-income provinces, hospital-based monitoring model, female births, and rural regions, respectively. National CHD birth prevalence increased gradually from western region to eastern region, but decreased gradually from southern to northern region. Relevant heterogeneity moderators including gender, geographic region, income levels, and monitoring models have been identified by subgroup analyses. Sensitivity analysis yielded consistent results. Total CHD birth prevalence in China increases continuously in the past 40 years. Significant differences in gender, geographical regions, income levels, and monitoring models were found. In the future, population wide prospective birth defect registries covering the entire Chinese population need to determine the exact birth prevalence.

Entities:  

Keywords:  Chinese; Congenital heart diseases; Meta-analysis; Prevalence; Spatial analysis; Systematic review

Year:  2020        PMID: 32519018     DOI: 10.1007/s10654-020-00653-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Epidemiological Aspects, Prenatal Screening and Diagnosis of Congenital Heart Defects in Beijing.

Authors:  Yanchun Zhang; Wen Zhang; Hongyan Xu; Kaibo Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-20

Review 2.  Kelch-like protein 3 in human disease and therapy.

Authors:  Yan Lin; Qian Li; Xiaofeng Jin
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

3.  Association of polymorphisms of FOLR1 gene and FOLR2 gene and maternal folic acid supplementation with risk of ventricular septal defect: a case-control study.

Authors:  Xinli Song; Jianhui Wei; Jing Shu; Yiping Liu; Mengting Sun; Ping Zhu; Jiabi Qin
Journal:  Eur J Clin Nutr       Date:  2022-03-10       Impact factor: 4.884

4.  Chinese Parents' Perceptions, Attitudes, and Treatment-Seeking Intentions Toward Congenital Heart Disease with Charitable Assistance: A Cross-Sectional Study in a Congenital Heart Center in Southern China.

Authors:  Wen-Peng Xie; Jian-Feng Liu; Yu-Qing Lei; Hua Cao; Qiang Chen
Journal:  Patient Prefer Adherence       Date:  2021-11-05       Impact factor: 2.711

5.  Pregestational diabetes mediates the association between maternal obesity and the risk of congenital heart defects.

Authors:  Xiao-Xia Wu; Ru-Xiu Ge; Le Huang; Fu-Ying Tian; Yi-Xuan Chen; Lin-Lin Wu; Jian-Min Niu
Journal:  J Diabetes Investig       Date:  2021-10-03       Impact factor: 4.232

6.  Association of China's two-child policy with changes in number of births and birth defects rate, 2008-2017.

Authors:  Hanyi Chen; Ting Wei; Haiyin Wang; Yi Zhou; Hua Chen; Lianghong Sun; Shaotan Xiao; Wuren Ma; Huijuan Zhao; Guanghua Chen; Xinlei Liang; Donglan Zhang; Weiwei Zheng; Yixin Zhou; Zhangsheng Yu
Journal:  BMC Public Health       Date:  2022-03-04       Impact factor: 3.295

7.  Evaluation of the association between maternal folic acid supplementation and the risk of congenital heart disease: a systematic review and meta-analysis.

Authors:  Zhengpei Cheng; Rui Gu; Zenglin Lian; Harvest F Gu
Journal:  Nutr J       Date:  2022-03-26       Impact factor: 3.271

8.  Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy.

Authors:  Yingying Xiao; Junpeng Li; Lisheng Qiu; Chuan Jiang; Yanhui Huang; Jinfen Liu; Qi Sun; Haifa Hong; Lincai Ye
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

9.  Nkx2-5 Regulates the Proliferation and Migration of H9c2 Cells.

Authors:  Hongshu Wang; Yong Liu; Shen Han; Yunfeng Zi; Yayong Zhang; Ruize Kong; Zu Liu; Zhibin Cai; Chongbin Zhong; Wei Liu; Lifeng Li; Lihong Jiang
Journal:  Med Sci Monit       Date:  2020-08-11

Review 10.  Global epidemiology of valvular heart disease.

Authors:  Sean Coffey; Ross Roberts-Thomson; Alex Brown; Jonathan Carapetis; Mao Chen; Maurice Enriquez-Sarano; Liesl Zühlke; Bernard D Prendergast
Journal:  Nat Rev Cardiol       Date:  2021-06-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.